ArticleWorld journal of hepatology2025
Performance of artificial intelligence in predicting hepatocellular carcinoma recurrence after thermal ablation: A systematic review.
Article in World journal of hepatology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundRecurrence prediction of hepatocellular carcinoma (HCC) after thermal ablation represents a challenge that can impact patients' quality of life. Artificial intelligence (AI)-based radiomics models applied to various imaging modalities can improve recurrence prediction, therefore guiding therapeutic decisions.
aimTo evaluate the effectiveness of AI-driven predictive models in predicting HCC recurrence.
methodsA systematic literature search in PubMed and Scopus was performed, and a total of ten studies were included in this systematic review. All studies included response prediction evaluation with AI models for patients who underwent thermal ablation for HCC. Deep learning and machine learning algorithms were utilized to evaluate the predictive performance and accuracy through metrics such as the area under the curve and concordance index.
resultsThe developed models demonstrated high accuracy in predicting local progression and recurrence, allowing a solid risk stratification. In particular, the integration of imaging data and clinical-laboratory variables optimized treatment selection, highlighting the superior ability of imaging models to predict therapeutic outcomes compared to clinical parameters alone. Furthermore, radiomic analysis of follow-up imaging enabled highly accurate detection of ablation site recurrence.
conclusionAI-driven predictive models based on multimodal radiomic analyses integrated with clinical data represent promising tools for predicting tumor recurrence after thermal ablation in HCC patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.